Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Harley-Davidson (HOG) Expands Product Portfolio, Dealerships

Published 01/02/2018, 08:49 PM
Updated 07/09/2023, 06:31 AM

On Jan 2, we issued an updated research report on Harley-Davidson, Inc. (NYSE:HOG) .

The company has set a long-term plan to boost sales growth. In fact, Harley-Davidson has set a target of launching 100 new motorcycles by 2027. In 2017, the Milwaukee, WI-based company unveiled two motorcycles, the Road King Special and a more affordable Street Rod 750. Also, the company is developing its first electric motorcycle, Project LiveWire. All these efforts are aiding its revenue growth.

Also, Harley-Davidson is making concerted efforts to improve its international reach and anticipates an increase of 50% in yearly volume by 2027. In sync with this strategy, the company is adding new dealerships across the globe. The company aims to add 150-200 new dealerships internationally by 2020.

Harley-Davidson has a long-term growth rate of 8.5%. Over the past 60 days, the Zacks Consensus Estimate for Harley-Davidson’s quarterly estimates has gone up.

The company has outperformed the industry it belongs to in the last three months. Its shares have gained 6.7% against the industry’s loss of 5.5 %.



Harley-Davidson currently has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

A few other top-ranked automobile stocks in the same space are Continental AG (OTC:CTTAY) , Allison Transmission Holdings, Inc. (NYSE:ALSN) and BorgWarner Inc. (NYSE:BWA) , each carrying a Zacks Rank #2 (Buy).

Continental AG has a long-term growth rate of 8.6%. The company’s shares have gained 39% in the past 12 months.

Allison Transmission has a long-term growth rate of 10%. The company’s shares have gained 28.4% in the past 12 months.

BorgWarner has a long-term growth rate of 8.6%. The company’s shares have gained 26.9% in the past 12 months.

Investor Alert: Breakthroughs Pending

A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.

Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.

Click here to see them >>


BorgWarner Inc. (BWA): Free Stock Analysis Report

Allison Transmission Holdings, Inc. (ALSN): Free Stock Analysis Report

Harley-Davidson, Inc. (HOG): Free Stock Analysis Report

Continental AG (CTTAY): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.